High rate of abnormal findings in Prenatal Exome Trio in low risk pregnancies and apparently normal fetuses
- 17 December 2021
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 42 (6) , 725-735
Abstract
Objective: Data on the value of exome sequencing in fetuses with no structural anomalies are limited, especially in the early stages of pregnancy and in low risk pregnancies. We investigated the yield of targeted clinical prenatal trio exome sequencing (pES) in pregnancies with and without fetal structural anomalies.Methods: We performed pES in 353 pregnancies: Group 1 included 143 pregnancies with high clinical suspicion for a genetic disease: pregnancies with increased nuchal translucency, ultrasound structural defects, intrauterine growth restriction, polyhydramnios, or effusion/nuchal edema. Group 2 included 210 pregnancies with no notable abnormal fetal ultrasound findings. 2a. Low risk pregnancies with minor ultrasound findings, referred to the geneticist due to mildly increased risk for genetic disease (50); and 2b. Normal pregnancy surveillance (160).Results: Overall, 26 (7.36%) fetal analyses had pathogenic (P)/likely pathogenic (LP) variants. In group 1, 20/143 (13.99%) cases had P/LP variants. In group 2, 6/210 (2.86%) cases were found to have P/LP variants [5/50 in (2a) and 1/160 in (2b)].Conclusion: These results show a high rate of abnormal findings on pES even in apparently normal pregnancies.Keywords
This publication has 30 references indexed in Scilit:
- Reporting genomic secondary findings: ACMG members weigh inGenetics in Medicine, 2015
- Clinical Exome Sequencing for Genetic Identification of Rare Mendelian DisordersJAMA, 2014
- Prenatal Whole-Genome Sequencing — Is the Quest to Know a Fetus's Future Ethical?New England Journal of Medicine, 2014
- Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian DisordersNew England Journal of Medicine, 2013
- The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: a review of the literaturePrenatal Diagnosis, 2013
- Fetal Loss Rate and Associated Risk Factors After Amniocentesis, Chorionic Villus Sampling and Fetal Blood SamplingUltraschall in der Medizin - European Journal of Ultrasound, 2012
- Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalitiesGenetics in Medicine, 2010
- Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemiaNature Genetics, 2010
- Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesThe American Journal of Human Genetics, 2010
- Ultrasonographically detectable markers of fetal chromosomal abnormalitiesThe Lancet, 1992